Etrixenal

Medicinal product

(Invented) name

Etrixenal

Active substance (s)

Naproksenas

Strength

250 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M01AE02, Naproxen

Marketing authorisation holder

Proenzi s.r.o., Čekija

Date of authorisation

2014-10-16

Date of renewal

2019-11-21

Documents

3637_01-02 pakuotes lapelis_2019-11-21.docx

3637_1-2 Etrixenal perr2019-11-21.docx

Etrixenal_LT_108_AR.pdf

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

LT/H/0108/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Naproksenas	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
57027	71136	1071136	lizdinė plokštelė	N10		Nereceptinis	LT/1/14/3637/001	Netiekiama	-	-	No	-	-	Download
60422	74699	1074699	lizdinė plokštelė	N20		Nereceptinis	LT/1/14/3637/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-01-31	Išregistruotas
2019-11-21	Perregistruotas
2014-10-16	Registruotas